oocytes to be fertilized, is a question thus far unanswered. This device releases levonorgestrel (LNG) into the uterine 1 Department of Obstetrics and Gynaecology, University Central cavity at a rate of 20 µg/24 h for at least 5 years Hospital of Helsinki, Haartmaninkatu 2, FIN-00290 and 2 Infertility (Luukkainen, 1991). Mean plasma LNG concentrations in Clinic, The Family Federation of Finland, Helsinki, Finland LNG-IUD users have ranged between 100-200 pg/ml over 3 To whom correspondence should be addressed a 6 year observation period (Luukkainen et al., 1990). Seven oocyte donors with a levonorgestrel-releasing intraSeveral mechanisms account for the contraceptive mode of uterine device (LNG-IUD) in situ (group A) underwent action of the LNG-IUD. The main findings are prevention ovarian stimulation with human menopausal gonadoof endometrial proliferation (Silverberg et al., 1986) , and trophin (HMG) after goserelin down-regulation, in eight thickening of the cervical mucus (Barbosa et al., 1990). treatment cycles. The donors in a control group (group B, Direct effects on sperm maturation and the process of n ϭ 16) were comparable in age, body mass index and fertilization cannot be ruled out (Luukkainen et al., 1990; parity characteristics. There were no statistically significant Rybo et al., 1993). Suppression of ovarian function (55% differences in response to ovarian hyperstimulation anovulatory cycles) has been shown during the first year of between the two groups. The number of oocytes recovered use (Xiao et al., 1990) . Later on, the majority of was 12.4 Ϯ 5.1 (SD) following stimulation with 27.9 Ϯ 9.3 women have ovulatory cycles, according to their circulating ampoules of HMG over 11.2 Ϯ 1.3 days in group A.
Introduction
carried out at the University Central Hospital of Helsinki (Helsinki, Oocyte donation has been carried out in Finland since the Finland). The characteristics of these donors are presented in Table   early 1990s. Mostly the oocytes are retrieved from young I. Every donor had at least one child. The LNG-IUD had been inserted 2-36 (mean 15) months (Table V) 
couple. This treatment is associated with many ethical
To compare the results of the study group with those of our problems (Robertson, 1989; Abdalla, 1994) , as well as oocyte donation programme in general, a control group was chosen complications (Sauer and Paulson, 1994) . One of these is (group B, n ϭ 16). For every group A donor, we took the the occurrence of unintentional pregnancies, which has been immediately preceding and following donors on the clinic's oocyte reported to happen during the treatment cycle (Sauer and donation list. Of these donors, 10 had no contraceptive method or Paulson, 1994) . Hence, these fertile women need an effective used condoms, four had recently discontinued contraceptive pills contraceptive during the treatment. Leiras Pharmaceutical, Turku, Finland), disturbs follicular Treatment protocols were similar in both centres. All donors underwent pituitary down-regulation with a long-acting gonadodevelopment in oocyte donors, or alters the capacity of the trophin-releasing hormone agonist (GnRHa), goserelin acetate (Zoladex ® ; Zeneca Pharma, Helsinki, Finland).
When suppression was achieved (no follicles Ͼ6mm and thin donors and the recipients in the two groups and to compare efficacy data concerning ovarian stimulation. The G-test (Sokal and Rohlf, 1995) was used to compare the fertilization and Discussion pregnancy rates and the proportion of embryos of different grades
In this study, we investigated whether or not a LNG-IUD between the two groups. The level of significance was set at P Ͻ0.05.
disturbs follicular maturation in oocyte donors during long GnRHa-HMG ovarian stimulation. Our two donor groups Results were comparable in age, body mass index and parity characteristics. As regards contraceptive methods in the There were no statistically significant differences in the main efficacy parameters of the donors' treatment cycles control group, four donors had recently discontinued using contraceptive pills, but thereafter had spontaneous ovulatory (Table II) . No cycle was cancelled in either group. One donor in group A developed moderate hyperstimulation cycles. Two control donors with a copper-IUD were not excluded, as this IUD has been shown to be free from syndrome (OHSS) and two group B donors had symptoms of mild OHSS. Tables III and IV show the outcome of insystemic steroidal effects (Sivin and Stern, 1994) . In recent years there has been a tendency towards simplification of vitro fertilization (IVF). There was no clear difference in the performance of the IVF procedure (Wikland et al., oocytes was the same in women with a LNG-IUD as in the control group. The numbers also compared well with 1994). In our oocyte programme, we have reduced visits to the clinic to a minimum and serum oestradiol measurement our earlier results (Söderström-Anttila et al., 1996) . Neither were there more empty follicles or functional cysts in the has been carried out only when regarded as necessary. Thus, we were unable to compare circulating oestradiol and study group than in the control group. It has been shown that plasma concentrations of LNG are highest during the progesterone concentrations in our two groups.
In LNG-IUD users, plasma concentrations of LNG (100-first year after IUD insertion and decline thereafter (Luukkainen et al., 1990) . In our study group, three donors 200 pg/ml) have been shown to have only occasional and weak effects on ovarian function; after the first year of use, who had used the LNG-IUD for Ͻ7 months responded similarly to HMG compared with those who had used it 85% of all menstrual cycles are ovulatory, as reflected in circulating progesterone concentrations (Nilsson et al., for 16-36 months. Two pregnancies started from a cycle in which the donor had used a LNG-IUD for 6 months 1984; Scholten et al., 1989) . However, despite ovulatory progesterone concentrations, Barbosa et al. (1995) detected (Table V) . In earlier reports, it has not been possible to exclude a a great number of disturbances of follicular maturation in LNG-IUD users. In addition, this contraceptive method is direct effect of LNG on oocyte maturation or other processes leading to fertilization. Croxatto et al. (1982) suggested that associated with an increased incidence of functional ovarian cysts (Robinson et al., 1989; Sivin and Stern, 1994) , subdermally implanted capsules containing LNG (Norplant) may act by interference with penetration of oocytes by which may reflect a disturbing effect on ovarian function. Furthermore, elevated circulating progesterone concentrations spermatozoa or interference with preimplantation phenomena. In LNG-IUD users, no fertilized eggs have been recovered in the early follicular phase have been suggested to impair follicular recruitment (Sims et al., 1994) . On the other from the reproductive tract (Ortiz and Croxatto, 1987) , suggesting that LNG might lower the fertilization potential. hand, in women under continuous low-dose progestogen administration, the duration of the functional life-span of In this study, oocytes in the LNG-IUD group had a higher rate of fertilization compared with the control group, but the anovulatory follicle did not differ from that of a normal follicle/corpus luteum unit (Faúndes et al., 1996) . We found the groups were too small to demonstrate a statistically significant difference in fertilization rates. The cleavage rate that following HMG stimulation, and in connection with goserelin, the number of developing follicles and retrieved was significantly higher in the LNG-IUD group than in the
